— Know what they know.
Not Investment Advice
Also trades as: SHIEF (OTC) · $vol 0M

STX.L LSE

Shield Therapeutics plc
1W: +14.4% 1M: +7.2% 3M: -2.5% YTD: -44.6% 1Y: -26.5% 3Y: -43.3% 5Y: -86.5%
£6.00 ($0.08)
-0.05 (-0.83%)
 
Weekly Expected Move ±12.0%
£5 £5 £6 £7 £7
LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 63 · £63.6M mcap · 409M float · 0.590% daily turnover

Balance Sheet Trends

Total Assets
$46M -5.9% ▼
5Y CAGR: +4.8%
Total Liabilities
$47M +77.2% ▲
5Y CAGR: +62.3%
Shareholders Equity
-$1M -108.9% ▼
Cash & Investments
$6M -59.8% ▼
5Y CAGR: +6.3%
Total Debt
$21M +4.0% ▲
5Y CAGR: +302.2%
Net Debt
$15M +145.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$3M$12M$3M$14M$6M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3M$12M$3M$14M$6M
Net Receivables$656K$2M$4M$11M$20M
Inventory$1M$2M$1M$3M$5M
Other Current Assets$0$1K-$9K$614K-$2M
Total Current Assets$5M$17M$10M$31M$30M
Property, Plant & Equip.$32K$304K$197K$673K$298K
Goodwill & Intangibles$27M$27M$12M$17M$15M
Long-Term Investments$0$0$0$0$798K
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$27M$27M$12M$18M$16M
Total Assets$33M$44M$22M$49M$46M
— Liabilities —
Accounts Payable$538K$4M$2M$4M$19M
Short-Term Debt$28K$156K$89K$168K$156K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$621K-$1M$7M$6M$7M
Total Current Liabilities$2M$3M$11M$11M$26M
Long-Term Debt$0$0$6M$20M$21M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$423K$1M$6M$20M$21M
Total Liabilities$2M$3M$17M$26M$47M
— Equity —
Common Stock$2M$3M$4M$12M$16M
Retained Earnings-$60M-$79M-$131M-$234M-$173M
Accumulated OCI$53K$1M-$9M-$7M-$6M
Total Stockholders Equity$30M$41M$5M$12M-$1M
Total Liabilities & Equity$33M$44M$22M$38M$46M
— Key Metrics —
Total Debt$28K$156K$6M$20M$21M
Net Debt-$3M-$12M$3M$6M$15M
Total Investments$0$0$0$0$798K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms